Your browser doesn't support javascript.
loading
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
Cosgrove, Catherine A; Lacey, Charles J; Cope, Alethea V; Bartolf, Angela; Morris, Georgina; Yan, Celine; Baden, Susan; Cole, Tom; Carter, Darrick; Brodnicki, Elizabeth; Shen, Xiaoying; Joseph, Sarah; DeRosa, Stephen C; Peng, Lili; Yu, Xuesong; Ferrari, Guido; Seaman, Mike; Montefiori, David C; Frahm, Nicole; Tomaras, Georgia D; Stöhr, Wolfgang; McCormack, Sheena; Shattock, Robin J.
Affiliation
  • Cosgrove CA; Centre for Infection, St George's, University of London, London, United Kingdom.
  • Lacey CJ; Hull York Medical School & Centre for Immunology and Infection, University of York, York, United Kingdom.
  • Cope AV; Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom.
  • Bartolf A; Centre for Infection, St George's, University of London, London, United Kingdom.
  • Morris G; Hull York Medical School & Centre for Immunology and Infection, University of York, York, United Kingdom.
  • Yan C; Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom.
  • Baden S; Centre for Infection, St George's, University of London, London, United Kingdom.
  • Cole T; Mucosal Infection & Immunity Group, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom.
  • Carter D; Infectious Disease Research Institute (IDRI), Seattle, WA, United States of America.
  • Brodnicki E; Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom.
  • Shen X; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
  • Joseph S; Medical Research Council, Clinical Trials Unit at UCL, University College London, London, United Kingdom.
  • DeRosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Peng L; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Yu X; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Ferrari G; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
  • Seaman M; Department of Surgery, Duke University Medical Center, Durham, NC, United States of America.
  • Montefiori DC; CAVD Neutralizing Antibody Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • Frahm N; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
  • Tomaras GD; Department of Surgery, Duke University Medical Center, Durham, NC, United States of America.
  • Stöhr W; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • McCormack S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
  • Shattock RJ; Department of Surgery, Duke University Medical Center, Durham, NC, United States of America.
PLoS One ; 11(5): e0152038, 2016.
Article in En | MEDLINE | ID: mdl-27159166
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: AIDS Vaccines / Env Gene Products, Human Immunodeficiency Virus Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: AIDS Vaccines / Env Gene Products, Human Immunodeficiency Virus Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Type: Article Affiliation country: United kingdom